Gout - An update of aetiology, genetics, co-morbidities and management

Maturitas. 2018 Dec:118:67-73. doi: 10.1016/j.maturitas.2018.10.012. Epub 2018 Oct 26.

Abstract

Gout is an increasingly common chronic disorder of urate crystal deposition that manifests as flares of acute inflammatory arthritis. Hyperuricaemia is a prerequisite and a fifth of both men and woman are hyperuricaemic. The prevalence of gout is much lower than the prevalence of hyperuricaemia for reasons that are not currently clear. Gout is more common in men than women prior to menopause due to the uricosuric effects of oestrogen, but after menopause the incidence of gout rises substantially in women. Co-morbidities are an important issue in gout, with cardiovascular disease, diabetes mellitus, obesity and chronic kidney disease all common in patients with gout. Environmental factors like diet affect the incidence of gout but there is little evidence to support an emphasis on diet in treating established gout. The diagnosis of gout is often made without the use of joint aspiration and validated diagnostic rules are available for both primary and secondary care as well as classification criteria for research use. The overarching principle of the management of gout with pharmacotherapy is the need to reduce serum urate levels to below a target of 0.30 mmol/L or 0.36 mmol/L depending on whether it is tophaceous or non-tophaceous respectively. The use of allopurinol has been researched extensively and newer strategies for safer effective dosing are now recommended. Newer agents have been introduced for the treatment of gout, including febuxostat and lesinurad. A number of important questions in the field are under current investigation.

Keywords: Allopurinol; Colchicine; Febuxostat; Gout; Hypertension; Urate; Uric acid.

Publication types

  • Review

MeSH terms

  • Allopurinol / therapeutic use
  • Chronic Disease
  • Comorbidity
  • Diet / adverse effects
  • Febuxostat / therapeutic use
  • Gout / epidemiology
  • Gout / etiology*
  • Gout / genetics
  • Gout / therapy*
  • Gout Suppressants / therapeutic use*
  • Humans
  • Hyperuricemia / complications
  • Probenecid / therapeutic use
  • Thioglycolates / therapeutic use
  • Triazoles / therapeutic use
  • Uric Acid / blood

Substances

  • Gout Suppressants
  • Thioglycolates
  • Triazoles
  • lesinurad
  • Febuxostat
  • Uric Acid
  • Allopurinol
  • Probenecid